Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension

被引:13
|
作者
Zhang, Duan-zhen [1 ]
Zhu, Xian-yang [1 ]
Meng, Jing [1 ]
Xue, Hong-mei [1 ]
Sheng, Xiao-tang [1 ]
Han, Xiu-min [1 ]
Cui, Chun-Sheng [1 ]
Wang, Qi-guang [1 ]
Zhang, Po [1 ]
机构
[1] Shenyang No Hosp, Dept Congenital Heart Dis, Shenyang 110016, Peoples R China
关键词
Pulmonary arterial hypertension; Vasoreactivity test; Hemodynamics; Congenital heart defect; INHALED NITRIC-OXIDE; AEROSOLIZED ILOPROST; VASODILATOR CAPACITY; VASCULAR-RESISTANCE; DISEASE; CHILDREN; THERAPY; BOSENTAN; GUIDELINES;
D O I
10.1016/j.ijcard.2010.04.093
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Detection of pulmonary vasoreactivity is important for the evaluation of patient with pulmonary arterial hypertension (PAH). The present study aimed to investigate the acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects (CHDs) and severe PAH. Patients and methods: From Mar 2007 to Nov 2009, 75 patients with severe PAH secondary to left-to-right shunt CHDs underwent acute vasodilator test using aerosolized iloprost (n=50) or intravenous adenosine (n=25). The hemodynamics were detected and analyzed. Results: Decreased mean pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR) were observed in 39 and 43 patients in the iloprost group, and in 16 and 19 patients in the adenosine group, respectively. However, the mean PAP was higher than 40 mm Hg in both groups. No significant difference was observed in the age and baseline hemodynamics between the patients with the decrease of PVR and mean pulmonary-to-aortic pressure (Pp/Ps) ratio greater than 10% and the remaining patients. Adenosine decreased both PAP and systemic arterial pressure significantly, while iloprost inhalation selectively reduced the PAP and increased the oxygen saturation of femoral arterial blood and the pulmonary-to-systemic flow (Qp/Qs) ratio. Compared with adenosine, iloprost caused a more profound decline in the Pp/Ps ratio, PVR and pulmonary-to-systemic vascular resistance ratio, and increase in the Qp/Qs ratio. Conclusions: The acute haemodynamic responses to adenosine and iloprost varied among the patients with CHDs and severe PAH. Different to adenosine, inhaled iloprost exerted selective pulmonary vasodilative effects and was beneficial for pulmonary gas exchange. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:433 / 437
页数:5
相关论文
共 50 条
  • [1] Acute Effect of Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Simple Congenital Heart Defects
    Li, Qiangqiang
    Dimopoulos, Konstantinos
    Zhang, Chen
    Zhu, Yan
    Liu, Qian
    Gu, Hong
    PEDIATRIC CARDIOLOGY, 2018, 39 (04) : 757 - 762
  • [2] Comparison of Acute Hemodynamic Effects of Aerosolized Iloprost and Inhaled Nitric Oxide in Adult Congenital Heart Disease with Severe Pulmonary Arterial Hypertension
    Zhang Caojin
    Huang Yigao
    Huang Tao
    Huang Wenhui
    Xia Chunli
    Huang Xinsheng
    INTERNAL MEDICINE, 2012, 51 (20) : 2857 - 2862
  • [3] Acute Effect of Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Simple Congenital Heart Defects
    Qiangqiang Li
    Konstantinos Dimopoulos
    Chen Zhang
    Yan Zhu
    Qian Liu
    Hong Gu
    Pediatric Cardiology, 2018, 39 : 757 - 762
  • [4] Invasive Hemodynamic and Vasoreactivity Testing with Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Defects
    Li, Qiangqiang
    He, Yuan
    Zhang, Chen
    Gu, Hong
    CARDIOLOGY DISCOVERY, 2023, 3 (04): : 232 - 238
  • [5] Acute responses to inhalation of Iloprost in patients with pulmonary hypertension
    Zhang Hong-liang
    Liu Zhi-hong
    Wang Yong
    Xiong Chang-ming
    Ni Xin-hai
    He Jian-guo
    Luo Qin
    Zhao Zhi-hui
    Zhao Qing
    Sun Xing-guo
    CHINESE MEDICAL JOURNAL, 2012, 125 (16) : 2826 - 2831
  • [6] Acute Effects of Rho-Kinase Inhibitor Fasudil on Pulmonary Arterial Hypertension in Patients With Congenital Heart Defects
    Xiao, Jia-wang
    Zhu, Xian-yang
    Wang, Qi-guang
    Zhang, Duan-zhen
    Cui, Chun-sheng
    Zhang, Po
    Chen, Huo-yuan
    Meng, Li-li
    CIRCULATION JOURNAL, 2015, 79 (06) : 1342 - 1348
  • [7] Can "Inoperable" Congenital Heart Defects Become Operable in Patients with Pulmonary Arterial Hypertension? Dream or Reality?
    Beghetti, Maurice
    Galie, Nazzareno
    Bonnet, Damien
    CONGENITAL HEART DISEASE, 2012, 7 (01) : 3 - 11
  • [8] Acute Hemodynamic Effects of Single Oral Dose of Bosentan in Patients with Pulmonary Arterial Hypertension Related to Congenital Heart Disease
    Ajami, Gholamhossein
    Ahmadipour, Maryam
    Amoozgar, Hamid
    Bourzoee, Mohammad
    Cheriki, Sirous
    Shakiba, Ali Mohammad
    Edraki, Mohammad Reza
    CONGENITAL HEART DISEASE, 2014, 9 (04) : 343 - 348
  • [9] The Effects of Perioperative Inhaled Iloprost on Pulmonary Hypertension with Congenital Heart Disease
    Sung, Ki Won
    Jeon, Yang Bin
    Kim, Na Yeon
    Park, Kook Yang
    Park, Chul Hyun
    Choi, Chang Hyu
    Choi, Deok Young
    CARDIOLOGY, 2013, 126 (04) : 224 - 229
  • [10] Long-term results of surgical repair of congenital heart defects in children with severe pulmonary arterial hypertension treated with perioperative inhaled iloprost
    Pac, Mustafa
    Sert, Dogan Emre
    Kocabeyoglu, Sinan Sabit
    Tasoglu, Irfan
    Kavurt, Ahmet Vedat
    Pac, Feyza Aysenur
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 25 (03): : 368 - 373